Correction of Fanconi Anemia Mutation Using the Crispr/Cas9 System

被引：0
|
作者：
Kawashima, Nozomu [1 ]
Okuno, Yusuke [1 ]
Sekiya, Yuko [1 ]
Wang, Xinan [1 ]
Narita, Atsushi [1 ]
Doisaki, Sayoko [1 ]
Kamei, Michi [1 ]
Nishio, Nobuhiro [1 ]
Muramatsu, Hideki [1 ]
Hama, Asahito [1 ]
Takahashi, Yoshiyuki [1 ]
Kojima, Seiji [1 ]
机构：
[1] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Fanconi Anemia Gene Editing by the CRISPR/Cas9 System
    Osborn, Mark J.
    Gabriel, Richard
    Webber, Beau R.
    DeFeo, Anthony P.
    McElroy, Amber N.
    Jarjour, Jordan
    Starker, Colby G.
    Wagner, John E.
    Joung, J. Keith
    Voytas, Daniel F.
    von Kalle, Christof
    Schmidt, Manfred
    Blazar, Bruce R.
    Tolar, Jakub
    HUMAN GENE THERAPY, 2015, 26 (02) : 114 - 126
  • [2] CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi Anemia
    Osborn, Mark J.
    Lonetree, Cara-Lin
    Webber, Beau R.
    Patel, Dharmeshkumar
    Dunmire, Samantha
    DeFeo, Anthony P.
    McElroy, Amber N.
    MacMillan, Margaret L.
    Wagner, John E.
    Blazar, Bruce R.
    Tolar, Jakub
    STEM CELLS AND DEVELOPMENT, 2016, 25 (20) : 1591 - 1603
  • [3] Benefits of Using the CRISPR/Cas9 System for the Correction of Genetic Mutations
    Sharipov, R. A.
    Omarov, M. A.
    Mulyukov, A. R.
    Dybova, A. I.
    Vyaseleva, E. T.
    Kayumova, N. B.
    Saitgalina, A. Sh.
    Ententeev, K. R.
    Iagafarov, I. R.
    Kuserbaev, I. V.
    Gubaeva, E. A.
    MOLECULAR GENETICS MICROBIOLOGY AND VIROLOGY, 2023, 38 (03) : 137 - 142
  • [4] Benefits of Using the CRISPR/Cas9 System for the Correction of Genetic Mutations
    R. A. Sharipov
    M. A. Omarov
    A. R. Mulyukov
    A. I. Dybova
    E. T. Vyaseleva
    N. B. Kayumova
    A. Sh. Saitgalina
    K. R. Ententeev
    I. R. Iagafarov
    I. V. Kuserbaev
    E. A. Gubaeva
    Molecular Genetics, Microbiology and Virology, 2023, 38 : 137 - 142
  • [5] CRISPR–Cas9 genome editing in human cells occurs via the Fanconi anemia pathway
    Chris D. Richardson
    Katelynn R. Kazane
    Sharon J. Feng
    Elena Zelin
    Nicholas L. Bray
    Axel J. Schäfer
    Stephen N. Floor
    Jacob E. Corn
    Nature Genetics, 2018, 50 : 1132 - 1139
  • [6] Correction: The application of CRISPR/Cas9 system in cervical carcinogenesis
    Chun Gao
    Ping Wu
    Lan Yu
    Liting Liu
    Hong Liu
    Xiangyu Tan
    Liming Wang
    Xiaoyuan Huang
    Hui Wang
    Cancer Gene Therapy, 2022, 29 : 625 - 626
  • [7] Photoactivatable CRISPR/Cas9 System
    E. A. Akhmetova
    V. M. Golyshev
    I. P. Vokhtantcev
    M. I. Meschaninova
    A. G. Venyaminova
    D. S. Novopashina
    Russian Journal of Bioorganic Chemistry, 2021, 47 : 496 - 504
  • [8] Photoactivatable CRISPR/Cas9 System
    Akhmetova, E. A.
    Golyshev, V. M.
    Vokhtantcev, I. P.
    Meschaninova, M., I
    Venyaminova, A. G.
    Novopashina, D. S.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2021, 47 (02) : 496 - 504
  • [9] CORRECTION OF F508DEL MUTATION IN VARIOUS CELL LINES USING CRISPR/CAS9
    Smirnikhina, S.
    Kondrateva, E.
    Adilgereeva, E.
    Anuchina, A.
    Zaynitdinova, M.
    Slesarenko, Y.
    Ustinov, K.
    Yasinovsky, M.
    Amelina, E.
    Voronina, E.
    Tabakov, V
    Lavrov, A.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S243 - S244
  • [10] CRISPR/Cas9
    杨丽
    中南医学科学杂志, 2016, 44 (05) : 585 - 585
12345